Retrospective cohort study comparing endoscopic ultrasound‐guided and percutaneous drainage of upper abdominal abscesses

医学 回顾性队列研究 经皮 内镜超声 外科 内镜超声检查 放射科 内窥镜检查
作者
Ana Yaiza Carbajo,Francisco Javier Brunie Vegas,Francisco Javier García‐Alonso,Marta Cimavilla,Raúl Torres Yuste,Paula Gil‐Simón,Carlos de la Serna‐Higuera,G.C. Fernández Pérez,Manuel Pérez‐Miranda
出处
期刊:Digestive Endoscopy [Wiley]
卷期号:31 (4): 431-438 被引量:25
标识
DOI:10.1111/den.13342
摘要

Background and Aim Endoscopic ultrasonography ( EUS )‐guided drainage ( EUS ‐D) has become the standard treatment for peripancreatic fluid collections. Its use in other intra‐abdominal abscesses has been reported, although there is limited evidence. Methods We carried out a single‐center retrospective cohort study comparing percutaneous drainage ( PCD ) and EUS ‐D of upper abdominal abscesses between January 2012 and June 2017. Pancreatic fluid collections and liver transplant recipients were excluded. Primary endpoints were technical and clinical success rates. Results We included 18 EUS ‐D (nine hepatic and nine intraperitoneal abscesses) and 62 PCD . There were no differences regarding age, gender and etiology. Size was larger in the PCD group (80 vs 65.5 mm, P = 0.04) and perivesicular location was more frequent in the PCD group (24.2% vs 11.1%, P = 0.003). In the EUS ‐D group, metal stents were deployed in 16 (88.9%) subjects (eight lumen‐apposing metal stents and eight self‐expandable metal stents), coaxial double‐pigtail plastic stents in six (33.3%) and lavage/debridement was carried out in five (27.8%). There were no significant differences in technical success ( EUS ‐D: 88.9%, PCD : 96.8%, P = 0.22) or clinical success ( EUS ‐D: 88.9%, PCD : 82.3%, P = 0.50), with no relapses in the EUS ‐D group and 10 (16.1%) in the PCD group ( P = 0.11). There were four (22.2%) adverse events in the EUS ‐D group, none of them severe, and 13 (21%) in the PCD group ( P = 0.91). Conclusions EUS ‐D is an alternative to PCD in the treatment of upper abdominal abscesses, reaching similar success, relapse and adverse events rates.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
安渝发布了新的文献求助10
刚刚
刚刚
Orange应助怡神001采纳,获得10
刚刚
LMF发布了新的文献求助10
1秒前
一小会完成签到,获得积分10
1秒前
Ava应助Seek采纳,获得30
2秒前
2秒前
2秒前
淡然的萝应助kk采纳,获得10
3秒前
轻松怜菡发布了新的文献求助10
3秒前
量子星尘发布了新的文献求助10
3秒前
3秒前
聪慧豁发布了新的文献求助10
3秒前
无辜秋珊发布了新的文献求助10
3秒前
任性山芙完成签到,获得积分10
4秒前
kjdsghbv完成签到,获得积分10
4秒前
lyapaper完成签到,获得积分10
4秒前
4秒前
4秒前
Hilda007发布了新的文献求助10
5秒前
烟花应助F_echo采纳,获得10
5秒前
星辰大海应助范良聪采纳,获得10
6秒前
wanci应助碧蓝丹烟采纳,获得10
6秒前
罗雪发布了新的文献求助10
6秒前
科研通AI6应助LY采纳,获得10
7秒前
7秒前
7秒前
烟花应助iui飞采纳,获得10
8秒前
lingck发布了新的文献求助10
9秒前
9秒前
满意沧海完成签到,获得积分10
9秒前
9秒前
小颖发布了新的文献求助10
10秒前
完美世界应助berg采纳,获得10
11秒前
科研通AI2S应助静心养性采纳,获得10
11秒前
欣喜的以丹完成签到,获得积分10
11秒前
12秒前
科研通AI6应助Brime采纳,获得10
12秒前
Ava应助受伤11采纳,获得10
13秒前
桐桐应助陈爽er采纳,获得10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
List of 1,091 Public Pension Profiles by Region 1001
Latent Class and Latent Transition Analysis: With Applications in the Social, Behavioral, and Health Sciences 500
On the application of advanced modeling tools to the SLB analysis in NuScale. Part I: TRACE/PARCS, TRACE/PANTHER and ATHLET/DYN3D 500
L-Arginine Encapsulated Mesoporous MCM-41 Nanoparticles: A Study on In Vitro Release as Well as Kinetics 500
Haematolymphoid Tumours (Part A and Part B, WHO Classification of Tumours, 5th Edition, Volume 11) 400
Virus-like particles empower RNAi for effective control of a Coleopteran pest 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5468825
求助须知:如何正确求助?哪些是违规求助? 4572157
关于积分的说明 14333943
捐赠科研通 4498964
什么是DOI,文献DOI怎么找? 2464789
邀请新用户注册赠送积分活动 1453376
关于科研通互助平台的介绍 1427939